david berz, md, phd, and philip bonomi, md discuss molecular diagnostics in nsclc
Published 8 years ago • 927 plays • Length 2:44
Download video MP4
Download video MP3
Similar videos
-
3:34
david berz, md, phd, and philip bonomi, md discuss use of liquid biopsies over surgical biopsies
-
1:21
david berz, md, phd, and philip bonomi, md discuss liquid biopsies versus tissue biopsies
-
2:27
david berz, md, phd, and philip bonomi, md discuss benefits of urine-based mutational screening
-
1:40
david berz, md, phd, and philip bonomi, md discuss options after an initial egfr exon 19 tki therapy
-
39:26
what is epigenetics? - with nessa carey
-
12:24
feeling good ! - david burns
-
21:07
brain metastasis: a cancer neuroscience perspective
-
2:30
gracecastuc088_lung_dr. bonomi on lung cancer targeted therapies
-
0:50
phil bonomi, md, on importance of checkpoint inhibitors in first-line nsclc setting
-
1:01
dr. philip bonomi: gefitinib and later generations of egfr inhibitors
-
0:52
dr. phil bonomi: recommending a repeat biopsy with acquired resistance to a targeted therapy
-
0:41
phil bonomi, md, offers opinion on whether met inhibitors are effective in metastatic nsclc
-
3:32
gracecastuc102_kidney_dr. bonomi on targeted therapy toxicity chemotherapy
-
1:18
which advanced nsclc patients recommend repeat biopsies for molecular testing
-
15:18
brain tumor genomics/epigenomics - david a. solomon, md, phd
-
0:48
phil bonomi, md, discusses costs of new lung cancer therapies relative to duration of therapy
-
6:34
molecular testing in lung cancer in 2016
-
1:28
dr. phillip bonomi - treatment of squamous cell lung cancer - jan. 24, 2017
-
1:20
targeted oncology precision medicine promo
-
1:57
meet dr. dan philbin
-
5:01
update on interstitial lung disease - david moller, m.d.
Clip.africa.com - Privacy-policy